Professional Highlights
Dr. Valerie Rusch has gained international recognition for her work in surgically treating mesothelioma, lung cancer and cancer of the thorax, esophagus and chest wall. Dr. Rusch currently serves as Chief of Thoracic Surgery at the Memorial Sloan-Kettering Cancer Center. She is also the Vice Chair for Clinical Research in the Department of Surgery and she holds the prestigious William G. Cahan Chair.
Valerie W. Rusch, M.D. is a surgeon and researcher who dedicates her career to thoracic surgical oncology and clinical research. She has worked extensively through a number of NCI Cooperative Groups and has participated on numerous Review Committees, Evaluation Panels, Subcommittees and Professional Societies to pioneer efforts to understand how patients will respond to different mesothelioma treatment modalities and to identify ways to be able to diagnose mesothelioma and other thoracic cancers at earlier stages (stage 1 and stage 2).
Educational Background and Professional Appointments
Dr. Rusch received her medical degree from the Columbia University College of Physicians and Surgeons. She completed residencies in both general and cardiothoracic Surgery at the University of Washington and from 1982-1983 she served as a Faculty Associate at The University of Texas M. D. Anderson Cancer Center. Prior to moving to Memorial Sloan-Kettering Cancer Center in 1989, Dr. Valerie Rusch completed a six year faculty assignment at the University of Washington.
At Memorial Sloan-Kettering Cancer Center Dr. Rusch holds several leadership positions as noted above. In addition, she is a member of the Executive Committee, Board of Governors of the American College of Surgeons, and has served as editor for The Oncologist as well as Chaired the Lung, Esophagus and Thoracic Malignancies Task Force.
Relevant Books by Dr. Valerie Rusch
Malignant Pleural Mesothelioma
Atlas of Procedures in Thoracic Cancer
General Thoracic Surgery (2 Vol. Set)
Relevant Articles by Dr. Valerie Rusch
Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma.
Positron emission tomography predicts survival in malignant pleural mesothelioma
Contact Information
Valerie Rusch, M.D.
Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, NY 10021
(212) 639-5873
Source
Memorial Sloan-Kettering Cancer Center Web Site Physician Biography
No comments:
Post a Comment